PF 592379

Drug Profile

PF 592379

Alternative Names: PF-000592379; PF-592,379

Latest Information Update: 18 Nov 2013

Price : $50

At a glance

  • Originator Pfizer
  • Class Analgesics; Erectile dysfunction therapies; Morpholines; Small molecules
  • Mechanism of Action Dopamine D3 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Erectile dysfunction; Pain

Most Recent Events

No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top